相关实验视频
Updated: Jul 20, 2025

06:47
Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
944
用血小板输血治疗急性四肢缺血症的抗凝药与严重的血小板缺血症
Khalid Shakfeh1,2, Damian A Laber3
1Internal Medicine, University of South Florida Morsani College of Medicine, Tampa, USA.
Cureus
|August 2, 2023
概括
在患有严重血小板缺血的患者中,治疗急性四肢缺血症 (ALI) 存在挑战. 本案例研究详细介绍了一种成功的策略,涉及抗凝药和外科手术期间血小板输血,用于癌症相关的血栓形成 (CAT).
科学领域:
- 血管外科 血管外科
- 血液学 血液学 血液学
- 在瘤学瘤学.
背景情况:
- 急性四肢缺血症 (ALI) 是一种危急的疾病,需要立即使用抗凝药和手术治疗.
- 血小板数量较低的状况 - - 血小板减少症 (Thrombocytopenia) - - 由于血液静止受损而使ALI的管理复杂化.
- 关于在严重血小板缺血患者中最佳治疗ALI的文献很少,特别是那些患有癌症相关血栓症 (CAT) 的患者.
研究的目的:
- 呈现严重的血小板缺血与肢体缺血的病例,这是癌症相关血栓形成 (CAT) 的次要原因.
- 在这个高风险患者群体中提出和评估抗凝血和外科手术期间血小板输血的管理策略.
- 评估成功重血管化的可行性,同时尽量减少出血并发症.
主要方法:
- 鉴定了一名患有严重的血小板缺血和由于CAT引起的ALI的患者.
- 采用了多学科的方法,专注于量身定制的抗凝治疗.
- 在外科手术期间进行了血小板输血,以保持足够的血静,以便进行外科手术.
主要成果:
- 已经成功地实现了受影响四肢的再血管化.
- 管理策略在术后期间防止了显著的不良出血事件.
- 患者耐受了这项干预,没有与出血或血栓形成相关的直接并发症.
结论:
- 跨学科的管理,包括战略性抗凝药和外科手术期间的血小板支持,可以使严重的血小板缺血患者的ALI治疗成功.
- 这一案例证明了在患有凝血功能受损的患者中管理复杂的ALI病例的可行方法.
- 需要进一步的研究来确定这种特定患者群体的长期结果和完善治疗方案.
相关概念视频
Venous Thrombosis III: Interprofessional Care
10
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
10
Anticoagulant Drugs: Low-Molecular-Weight Heparins
753
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
753
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
563
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
563
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
10
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
10
Peripheral Artery Disease III: Interprofessional Care
11
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
11
Formation of the Platelet Plug
6.7K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.7K

